Pharma News

MHRA approves first oral advanced therapy for Crohn’s disease

The MHRA has approved the first marketing authorisation globally for the use of RINVOQ®▼ (upadacitinib) in Crohn’s disease. The Medicines…

Read More »

MD Anderson partners with Federation Bio to develop microbiome

MD Anderson and Federation Bio will design and develop a synthetic microbial consortium to treat immunotherapy-resistant cancer patients. Credit: National…

Read More »

Working in a Male-Dominated Field

It is no easy feat to break into a male-dominated field as a woman, no less the bio/pharmaceutical industry. Piper…

Read More »

first biosimilar to HUMIRA available in US

AMJEVITA™, the first biosimilar to Humira® is now available in the US, based on four years of real-world experience in…

Read More »

Antitrust watchdogs have pharma in their sights, and the landscape is getting thornier

Listen to the article 7 min This audio is auto-generated. Please let us know if you have feedback. The Biden…

Read More »

Pharmapack Europe Awards 2023 winners announced

Awards for innovative drug delivery solutions, reusable connected devices and recyclable packaging have been announced at Pharmapack Europe 2023. The…

Read More »

Endevica Bio and Orbit Discovery unite to boost cachexia therapeutics

Orbit Discovery Limited – a company which focuses on peptide hits – has reached a research deal…

Read More »

Cidara Therapeutics expands partnership with WuXi XDC

CD421 is Cidara’s lead oncology candidate. Credit: National Cancer Institute on Unsplash. Cidara Therapeutics has announced the expansion of its…

Read More »

Bill & Melinda Gates Foundation funding for MIP Discovery

MIP Discovery – a company focused on detection reagents – has received a significant grant of funds…

Read More »

US FDA approves GSK’s Jesduvroq to treat anaemia of CKD

GSK’s Jesduvroq is claimed to be the only HIF-PHI approved in the US. Credit: GSK plc. The US Food and…

Read More »